Results 171 to 180 of about 86,629 (276)

Kinetics of MM1.S Multiple Myeloma Cells in a 3D Polymer Particle Culture System with Bone Marrow Stromal Cells and Bortezomib. [PDF]

Pharmaceuticals (Basel)
Aizawa S, Yuda M, Hirai S, Tsuboi I, Koike T, Hatta Y, Miura K, Yasuda M.   +7 more
europepmc   +1 more source

Supplemental Table 1 from Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption

, 2023
Leqin Xu, Jianbin Luo, Rongrong Jin, Zhiying Yue, Peng Sun, Zhengfeng Yang, Xinghai Yang, Wei Wan, Jishen Zhang, Shichang Li, Mingyao Liu, Jianru Xiao   +11 more
openalex   +1 more source

Mechanisms of action and clinical development of elotuzumab [PDF]

, 2017
Colonna, Marco, Ritchie, David
core   +2 more sources

Depletion of IgG-producing plasma cells in the colon by treatment of proteasome inhibitor ameliorates chronic DSS-induced colitis in mice. [PDF]

Sci Rep
Ebihara S, Kimoto Y, Katsumoto R, Konishi N.   +3 more
europepmc   +1 more source

A novel deep optimal transport framework reveals prostate cancer risk heterogeneity, Alzheimer’s disease risk heterogeneity, and myeloma cells associated with a short-term sham bortezomib response and progressive disease [PDF]

Ziyu Liu, Sihong Li, Justin L. Couetil, Jie Zhang, Kun Huang, Travis S. Johnson   +5 more
openalex   +1 more source

Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone. [PDF]

Hematol Rep
Peláez Casillas N, Verdaguer Muñoz JM, Rodríguez Valiente A, Romera Martínez I, García Berrocal JR.   +4 more
europepmc   +1 more source

Bortezomib in Anti-Cancer Activity: A Potential Drug [PDF]

, 2016
Rajagopal Appavu
openalex   +1 more source

Atypical presentation of DRESS/DiHS mimicking an acquired ichthyosis: A case report of bortezomib-induced severe erythroderma in multiple myeloma. [PDF]

SAGE Open Med Case Rep
Lu C, Belmesk L, Bélisle A, Masse MS, Ouellette S, Cote B.   +5 more
europepmc   +1 more source

Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry. [PDF]

Sci Rep
Babu EM, Fermahan S, Bowen J, Arnold K, Broe A, Lay-Flurrie S, Matsakidis P, Chetty M, Pawlyn C.   +8 more
europepmc   +1 more source

The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma

, 2016
Shigeo Hashimoto, Takashi Kuroha, Toshio Yano, Naoko Sato, Tatsuo Furukawa   +4 more
openalex   +2 more sources